Northeast Asia

South Korean company Hanwha Systems, a defence and IT service provider, has set the ball rolling for its up to W460.1bn ($383.6m) IPO.

CK Hutchison, the Hong Kong conglomerate, took more than €10bn of orders on Tuesday for a six-tranche bond in euros and sterling as it opted not to squeeze the pricing as much as other recent deals.

South Korea's Shinhan Bank has taken its first step into the euro bond market, raising €500m of green funding on the back of €650m of demand.

Sichuan Languang Justbon Services Group, a property management company, has kicked off a short IPO roadshow, aiming to raise up to HK$1.67bn ($213.4m) from a Hong Kong SAR listing.

Health and Happiness International Holdings, a China-based supplier of paediatric nutritional and baby care products, has returned to the loan market for a multi-tranche transaction.

The Securities Association of China (SAC) has told onshore securities houses to improve the quality of their research reports on Star Market companies. The move may help securities houses better price IPOs on the bourse, said bankers.

GlobalCapital China is pleased to invite you to participate in the GlobalCapital China Capital Market Awards 2019. Inaugurated last year under the GlobalRMB banner, the awards celebrate the accomplishments of the leading players in the renminbi debt capital markets, onshore and offshore, as well as key service providers.

Hong Kong Stock Exchanges and Clearing has dropped its plan to acquire the London Stock Exchange Group (LSEG), shelving the £31.6bn bid that would have created a powerhouse among financial marketplaces.

Real estate developer Helenbergh China Holdings has priced its first dollar bond, raising $300m amid constant demand for yield from investors.

Three public sector borrowers announced dollar benchmarks on Monday, rekindling the market after a quiet week.

Corporate, FIG and SSA issuers placed floating rate notes this week, pegged to Euribor, Sonia and Libor. With so many issuers coming to market, bankers are interested to see which other borrowers 'take advantage of the liquidity'.

Chinese biotechnology firm Innovent Biologics has raised HK$2.39bn ($304.3m) after selling a chunk of stock through a top-up placement.